Two patients have died after undergoing cosmetic surgeries at Svelta Plastic Surgery in Coral Gables, Florida, prompting investigations and lawsuits. The clinic, previously known as Seduction Cosmetic Center, attracted clients nationwide through social media influencers. The incidents raise concerns about patient safety and regulatory oversight in medical tourism and aesthetic surgery, which is critical for overseas buyers and distributors monitoring clinic standards and supply-chain risks.
Clinic profile and marketing strategy
Svelta Plastic Surgery, located in a residential and commercial area of Coral Gables, focused on medical tourism and outpatient plastic surgery. Its business model relied on social media accounts with hundreds of thousands of followers to offer bundled surgical packages. The clinic changed its name after previous incidents, when doctors linked to the former Seduction Cosmetic Center received sanctions from the state medical board. Current doctors listed on the website have no active sanctions in Florida Department of Health records.
Details of procedures and deaths
The first case involved a 35-year-old woman from Kentucky who underwent a "mommy makeover" on April 29, including breast implants, abdominoplasty, and fat transfer to the buttocks. She suffered cardiac arrest during anesthesia and died at a Miami-Dade County hospital. The second death occurred on May 26, involving a 19-year-old man from Tennessee who developed fatal postoperative complications after rhinoplasty at the same facility.
Legal status and company statement
Lawyers for the victims' families have filed lawsuits against the medical corporation. The clinic's management issued a written statement saying they are collecting medical records to evaluate the incidents. The company declined to provide specific technical data on surgeon performance or causes of medical events, citing U.S. federal health data privacy regulations.
Regulatory and channel signals
This case highlights potential risks in medical tourism and aesthetic surgery supply chains, particularly for clinics using social media to attract out-of-state patients. Overseas distributors and clinic buyers should verify facility credentials, surgeon licensing, and incident history before partnering. The name change and prior sanctions suggest a need for enhanced due diligence in sourcing aesthetic services and products.
Source: Read the original report | Published: June 13, 2026